(Q38104269)

28 August 2017

title

The use of biomarkers in the patient with heart failure (English)

1 reference

28 August 2017

0 references

0 references

1 reference

Punam Chowdhury

1

1 reference

28 August 2017

Devin Kehl

series ordinal

2

1 reference

28 August 2017

Rajiv Choudhary

series ordinal

3

1 reference

28 August 2017

Alan Maisel

series ordinal

4

1 reference

28 August 2017

language of work or name

1 reference

1 June 2013

1 reference

Current cardiology reports

28 August 2017

published in

1 reference

28 August 2017

volume

15

1 reference

28 August 2017

issue

6

1 reference

28 August 2017

page(s)

372

1 reference

Heart Disease and Stroke Statistics--2010 Update: A Report From the American Heart Association

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Emerging biomarkers in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

ABC of heart failure. Pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Natriuretic peptides: Diagnostic and therapeutic use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

ANP is cleared much faster than BNP in patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Direct comparison of serial B-type natriuretic peptide and NT-proBNP levels for prediction of short- and long-term outcome in acute decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

In-hospital percentage BNP reduction is highly predictive for adverse events in patients admitted for acute heart failure: the Italian RED Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Profiling B-type natriuretic peptide in a stable heart failure population: a valuable adjunct to care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Pro-B-type natriuretic peptide(1-108) circulates in the general community: plasma determinants and detection of left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Heart failure outcomes and benefits of NT-proBNP-guided management in the elderly: results from the prospective, randomized ProBNP outpatient tailored chronic heart failure therapy (PROTECT) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Optimizing fluid management in patients with acute decompensated heart failure (ADHF): the emerging role of combined measurement of body hydration status and brain natriuretic peptide (BNP) levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

The role of natriuretic peptide testing in guiding chronic heart failure management: review of available data and recommendations for use

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

T1/ST2-deficient mice demonstrate the importance of T1/ST2 in developing primary T helper cell type 2 responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Prognostic utility of novel biomarkers of cardiovascular stress: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

ST2 protein induced by inflammatory stimuli can modulate acute lung inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

The increase in serum soluble ST2 protein upon acute exacerbation of idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Acute eosinophilic pneumonia with increased soluble ST2 in serum and bronchoalveolar lavage fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Soluble ST2 plasma concentrations predict 1-year mortality in acutely dyspneic emergency department patients with pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Analytical and clinical evaluation of a novel high-sensitivity assay for measurement of soluble ST2 in human plasma--the Presage ST2 assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Identification of serum soluble ST2 receptor as a novel heart failure biomarker

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

High-sensitivity ST2 for prediction of adverse outcomes in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Role of ST2 in non-ST-elevation acute coronary syndrome in the MERLIN-TIMI 36 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Serum soluble ST2: a potential novel mediator in left ventricular and infarct remodeling after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Measurement of the interleukin family member ST2 in patients with acute dyspnea: results from the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Interleukin family member ST2 and mortality in acute dyspnoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Prognostic utility of ST2 in patients with acute dyspnea and preserved left ventricular ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Association of ST2 levels with cardiac structure and function and mortality in outpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Troponin I degradation and covalent complex formation accompanies myocardial ischemia/reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Release of cardiac troponin I from viable cardiomyocytes is mediated by integrin stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Vascular endothelial dysfunction and mortality risk in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Troponin elevation in heart failure prevalence, mechanisms, and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Troponin elevation in patients with heart failure: on behalf of the third Universal Definition of Myocardial Infarction Global Task Force: Heart Failure Section

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Serial biomarker measurements in ambulatory patients with chronic heart failure: the importance of change over time

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Usefulness of an elevated troponin-I in predicting clinical events in patients admitted with acute heart failure and acute coronary syndrome (from the RITZ-4 trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Cardiac troponin-I and risk of heart failure: a community-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Cardiac troponin and outcome in acute heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

The role of plasma biomarkers in acute heart failure. Serial changes and independent prognostic value of NT-proBNP and cardiac troponin-T.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Serial changes in high-sensitive troponin I predict outcome in patients with decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Galectin-3: a novel mediator of heart failure development and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Galectin-3, cardiac structure and function, and long-term mortality in patients with acutely decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Performance characteristics of the ARCHITECT Galectin-3 assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Adrenomedullin: potential in physiology and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Midregion prohormone adrenomedullin and prognosis in patients presenting with acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Mid-regional pro-adrenomedullin as a novel predictor of mortality in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

The predictive value of stable precursor fragments of vasoactive peptides in patients with chronic heart failure: data from the GISSI-heart failure (GISSI-HF) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Copeptin, a fragment of the vasopressin precursor, as a novel predictor of outcome in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Changes in plasma copeptin, the c-terminal portion of arginine vasopressin during water deprivation and excess in healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Neurohormonal activation in congestive heart failure and the role of vasopressin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

C-terminal provasopressin (copeptin) is associated with left ventricular dysfunction, remodeling, and clinical heart failure in survivors of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Increased 90-day mortality in patients with acute heart failure with elevated copeptin: secondary results from the Biomarkers in Acute Heart Failure (BACH) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Copeptin, a surrogate marker of vasopressin, is associated with microalbuminuria in a large population cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Renal impairment and outcomes in heart failure: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Heart disease and stroke statistics--2011 update: a report from the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Heart failure, chronic kidney disease, and biomarkers--an integrated viewpoint--.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Cystatin C and mortality risk in the elderly: the health, aging, and body composition study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Clinical and subclinical cardiovascular disease and kidney function decline in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: more than simply a marker of glomerular filtration rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Prognostic value of cystatin C in acute heart failure in relation to other markers of renal function and NT-proBNP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Prognostic value of cystatin C on admission in heart failure with preserved ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Association of cystatin C with left ventricular structure and function: the Dallas Heart Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Neutrophil gelatinase-associated lipocalin is a novel mineralocorticoid target in the cardiovascular system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure: the NGAL EvaLuation Along with B-type NaTriuretic Peptide in acutely decompensated heart failure (GALLANT) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Relation of systemic and urinary neutrophil gelatinase-associated lipocalin levels to different aspects of impaired renal function in patients with acute decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Urinary neutrophil gelatinase associated lipocalin (NGAL), a marker of tubular damage, is increased in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Biomarkers for the early detection of acute kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Improved performance of urinary biomarkers of acute kidney injury in the critically ill by stratification for injury duration and baseline renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Temporal relationship and predictive value of urinary acute kidney injury biomarkers after pediatric cardiopulmonary bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Diagnostic and prognostic stratification in the emergency department using urinary biomarkers of nephron damage: a multicenter prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Kidney injury molecule-1 and N-acetyl-β-D-glucosaminidase in chronic heart failure: possible biomarkers of cardiorenal syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Tubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Relation between cardiac troponin I and mortality in acute decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Recommendations for the use of cardiac troponin measurement in acute cardiac care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0372-4

Serum levels of the interleukin-1 receptor family member ST2, cardiac structure and function, and long-term mortality in patients with acute dyspnea

21 January 2018

1 reference

12 December 2020

The utility of troponin measurement to detect myocardial infarction: review of the current findings.

1 reference

12 December 2020

Galectin-3: a novel blood test for the evaluation and management of patients with heart failure

1 reference

12 December 2020

Profiles of serial changes in cardiac troponin T concentrations and outcome in ambulatory patients with chronic heart failure

1 reference

12 December 2020

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology

1 reference

12 December 2020

Soluble ST2 monitoring provides additional risk stratification for outpatients with decompensated heart failure

1 reference

12 December 2020

Pathobiology of troponin elevations: do elevations occur with myocardial ischemia as well as necrosis?

1 reference

12 December 2020

Episodes of acute heart failure syndrome are associated with increased levels of troponin and extracellular matrix markers

1 reference

12 December 2020

Kidney injury molecule-1 correlates with kidney function in heart allograft recipients

1 reference

12 December 2020

N-terminal pro-B-type natriuretic peptide testing improves the management of patients with suspected acute heart failure: primary results of the Canadian prospective randomized multicenter IMPROVE-CHF study

1 reference

12 December 2020

[Assessment of renal function, iatrogenic hyperkalemia and acute renal dysfunction in cardiology. Contrast-induced nephropathy]

1 reference

12 December 2020

Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase.

1 reference

12 December 2020

Elevated soluble ST2 protein levels in sera of patients with asthma with an acute exacerbation

1 reference

12 December 2020

A novel biochemical approach to congestive heart failure: cardiac troponin T

1 reference

12 December 2020

10.1007/S11886-013-0372-4

Identifiers

DOI

1 reference

Dimensions Publication ID

28 August 2017

1023840976

0 references

1 reference